SHOWKAT A. HAJI, MD

Assistant Professor
Medicine-Cardiology

Office: A312 COLEMAN BUILDING
956 COURT AVENUE
MEMPHIS TN 381632116
Tel: (901) 448-5750
shaji@uthsc.edu

Education

  • Fellowship, Ochsner Clinic Foundation Hospital, New Orleans, LA, Interventional Cardiology and Peripheral Interventions
  • Fellowship, Tulane University, New Orleans, LA, Cardiology
  • Clinical Fellowship, Tulane University, New Orleans, LA, Heart Failure and Transplantation
  • Residency, Nassau University Medical Center, NY, Internal Medicine
  • M.D., University of Kashmir, Srinagar, India, Medicine

Clinical Care Specialty/Interest

Peripheral and high risk coronary interventions

Venous insufficiency ablations

Carotid interventions

TEE and taking care of complex cardiac patients including advanced Heart Failure

ICD/Pacemaker implantation

Publications

  1. Haji, SA, Ulusoy, RE, Patel, DA, Srinivasan, SR, Chen, W, Delafontaine, P, Berenson, GS. Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study). Am J Cardiol, 98 (9), 1234-7, 2006.
  2. Haji, SA, Avery, RK, Yamani, MH, Tuzcu, EM, Crowe, TD, Cook, DJ, Mawhorter, SD, Hobbs, R, Young, JB, Smedira, N, Starling, RC. Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. J Heart Lung Transplant, 25 (3), 294-7, 2006.
  3. Haji, SA. Dyspnea and stress testing. N Engl J Med, 354 (8), 871-3; author reply 871-3, 2006.
  4. Glancy, DL, Haji, SA. ECG of the month. Slow bigeminal rhythm. Low atrial or junctional rhythm, second degree atrioventricular block, right ventricular escape beats, ventricular escape-capture bigeminy, ventriculophasic atrial arrhythmia, and right bundle branch block. J La State Med Soc, 156 (4), 173-4, 2004.
  5. Haji, SA, Starling, RC, Avery, RK, Mawhorter, S, Tuzcu, EM, Schoenhagen, P, Cook, DJ, Ratliff, NB, McCarthy, PM, Young, JB, Yamani, MH. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant, 23 (3), 277-83, 2004.
  6. Yamani, MH, Tuzcu, EM, Starling, RC, Young, JB, Cook, DJ, Haji, SA, Abdo, A, Crowe, T, Hobbs, R, Rincon, G, Bott-Silverman, C, McCarthy, PM, Ratliff, NB. Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound. J Heart Lung Transplant, 21 (8), 850-9, 2002.
  7. Yamani, MH, Haji, SA, Starling, RC, Tuzcu, EM, Ratliff, NB, Cook, DJ, Abdo, A, Crowe, T, Secic, M, McCarthy, P, Young, JB. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. J Am Coll Cardiol, 39 (6), 970-7, 2002.
  8. Yamani, MH, Haji, SA, Starling, RC, Kelly, L, Albert, N, Knack, DL, Young, JB. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact. Am Heart J, 142 (6), 998-1002, 2001.
  9. Haji, SA, Movahed, A. Update on digoxin therapy in congestive heart failure. Am Fam Physician, 62 (2), 409-16, 2000.
  10. Haji, SA, Movahed, A. Right ventricular infarction--diagnosis and treatment. Clin Cardiol, 23 (7), 473-82, 2000.